Skip to main content
. 2018 Mar 13;8:4459. doi: 10.1038/s41598-018-22222-y

Figure 1.

Figure 1

Prevalence of IDH105GGT. (A) Comparison of IDH105GGT between controls and patients with brain tumors. (B) IDH105GGT in grade II, III and IV brain tumors. (C) IDH105GGTin gliomas with and without IDH tumor missense mutation. (D) IDH105GGT in grade II and III gliomas with and without IDH tumor missense mutation and in grade IV without IDH tumor missense mutation. IDH105GGT: cases with IDH105GGT; No-IDH105GGT: cases without the IDH105GGT; GII: grade II brain tumors; GIII: grade III brain tumors; GIV: grade IV brain tumors; GBM: glioblastoma; R132: cases with IDH-missense mutation; WT: wild type.